241 related articles for article (PubMed ID: 19404939)
1. Induction of the expression of profibrotic cytokines and growth factors in normal human peripheral blood monocytes by gadolinium contrast agents.
Wermuth PJ; Del Galdo F; Jiménez SA
Arthritis Rheum; 2009 May; 60(5):1508-18. PubMed ID: 19404939
[TBL] [Abstract][Full Text] [Related]
2. Induction of a type I interferon signature in normal human monocytes by gadolinium-based contrast agents: comparison of linear and macrocyclic agents.
Wermuth PJ; Jimenez SA
Clin Exp Immunol; 2014 Jan; 175(1):113-25. PubMed ID: 24111526
[TBL] [Abstract][Full Text] [Related]
3. Gadolinium-based compounds induce NLRP3-dependent IL-1β production and peritoneal inflammation.
Schmidt-Lauber C; Bossaller L; Abujudeh HH; Vladimer GI; Christ A; Fitzgerald KA; Latz E; Gravallese EM; Marshak-Rothstein A; Kay J
Ann Rheum Dis; 2015 Nov; 74(11):2062-9. PubMed ID: 24914072
[TBL] [Abstract][Full Text] [Related]
4. Gadolinium compounds signaling through TLR4 and TLR7 in normal human macrophages: establishment of a proinflammatory phenotype and implications for the pathogenesis of nephrogenic systemic fibrosis.
Wermuth PJ; Jimenez SA
J Immunol; 2012 Jul; 189(1):318-27. PubMed ID: 22649203
[TBL] [Abstract][Full Text] [Related]
5. Effects of magnetic resonance imaging contrast agents on human umbilical vein endothelial cells and evaluation of magnetic resonance imaging contrast media-triggered transforming growth factor-beta induction in dermal fibroblasts (HSF) as a model for nephrogenic systemic fibrosis.
Wiesinger B; Kehlbach R; Hemsen J; Bebin J; Bantleon R; Schwenzer N; Spira D; Claussen CD; Wiskirchen J
Invest Radiol; 2011 Jan; 46(1):71-6. PubMed ID: 21139503
[TBL] [Abstract][Full Text] [Related]
6. NSF evaluation of gadolinium biodistribution in renally impaired rats: Using novel metabolic Gd2O3 nanoparticles coated with β-cyclodextrin (Gd2O3@PCD) in MR molecular imaging.
Ashouri H; Riyahi Alam N; Khoobi M; Haghgoo S; Rasouli Z; Gholami M
Magn Reson Imaging; 2024 Apr; 107():120-129. PubMed ID: 38215955
[TBL] [Abstract][Full Text] [Related]
7. Persistent activation of dermal fibroblasts from patients with gadolinium-associated nephrogenic systemic fibrosis.
Piera-Velazquez S; Louneva N; Fertala J; Wermuth PJ; Del Galdo F; Jimenez SA
Ann Rheum Dis; 2010 Nov; 69(11):2017-23. PubMed ID: 20570839
[TBL] [Abstract][Full Text] [Related]
8. Tissue gadolinium deposition in renally impaired rats exposed to different gadolinium-based MRI contrast agents: evaluation with inductively coupled plasma mass spectrometry (ICP-MS).
Sato T; Ito K; Tamada T; Kanki A; Watanabe S; Nishimura H; Tanimoto D; Higashi H; Yamamoto A
Magn Reson Imaging; 2013 Oct; 31(8):1412-7. PubMed ID: 23643157
[TBL] [Abstract][Full Text] [Related]
9. Effects of gadolinium contrast agents in naïve and nephrectomized rats: relevance to nephrogenic systemic fibrosis.
Grant D; Johnsen H; Juelsrud A; Løvhaug D
Acta Radiol; 2009 Mar; 50(2):156-69. PubMed ID: 19160079
[TBL] [Abstract][Full Text] [Related]
10. The involvement of pro-inflammatory cytokines in nephrogenic systemic fibrosis - a mechanistic hypothesis based on preclinical results from a rat model treated with gadodiamide.
Steger-Hartmann T; Raschke M; Riefke B; Pietsch H; Sieber MA; Walter J
Exp Toxicol Pathol; 2009 Nov; 61(6):537-52. PubMed ID: 19131226
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of NSF: New evidence challenging the prevailing theory.
Newton BB; Jimenez SA
J Magn Reson Imaging; 2009 Dec; 30(6):1277-83. PubMed ID: 19937925
[TBL] [Abstract][Full Text] [Related]
12. Effects of Gadodiamide on cell proliferation and collagen production in cultured human dermal fibroblasts.
Ozawa Y; Hayashi S; Hamasaki Y; Hatamochi A
Arch Dermatol Res; 2016 Dec; 308(10):695-701. PubMed ID: 27683230
[TBL] [Abstract][Full Text] [Related]
13. Gadolinium contrast agent-induced CD163+ ferroportin+ osteogenic cells in nephrogenic systemic fibrosis.
Swaminathan S; Bose C; Shah SV; Hall KA; Hiatt KM
Am J Pathol; 2013 Sep; 183(3):796-807. PubMed ID: 23867799
[TBL] [Abstract][Full Text] [Related]
14. Nephrogenic systemic fibrosis.
Bardin T; Richette P
Curr Opin Rheumatol; 2010 Jan; 22(1):54-8. PubMed ID: 19881349
[TBL] [Abstract][Full Text] [Related]
15. The role of residual gadolinium in the induction of nephrogenic systemic fibrosis-like skin lesions in rats.
Pietsch H; Raschke M; Ellinger-Ziegelbauer H; Jost G; Walter J; Frenzel T; Lenhard D; Hütter J; Sieber MA
Invest Radiol; 2011 Jan; 46(1):48-56. PubMed ID: 20938346
[TBL] [Abstract][Full Text] [Related]
16. NFκB activation and stimulation of chemokine production in normal human macrophages by the gadolinium-based magnetic resonance contrast agent Omniscan: possible role in the pathogenesis of nephrogenic systemic fibrosis.
Del Galdo F; Wermuth PJ; Addya S; Fortina P; Jimenez SA
Ann Rheum Dis; 2010 Nov; 69(11):2024-33. PubMed ID: 20959327
[TBL] [Abstract][Full Text] [Related]
17. Low risk for nephrogenic systemic fibrosis in nondialysis patients who have chronic kidney disease and are investigated with gadolinium-enhanced magnetic resonance imaging.
Chrysochou C; Power A; Shurrab AE; Husain S; Moser S; Lay J; Salama AD; Kalra PA
Clin J Am Soc Nephrol; 2010 Mar; 5(3):484-9. PubMed ID: 20093350
[TBL] [Abstract][Full Text] [Related]
18. Gadolinium-Induced Fibrosis.
Todd DJ; Kay J
Annu Rev Med; 2016; 67():273-91. PubMed ID: 26768242
[TBL] [Abstract][Full Text] [Related]
19. A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media.
Sieber MA; Pietsch H; Walter J; Haider W; Frenzel T; Weinmann HJ
Invest Radiol; 2008 Jan; 43(1):65-75. PubMed ID: 18097279
[TBL] [Abstract][Full Text] [Related]
20. Nephrogenic systemic fibrosis: history and epidemiology.
Thomsen HS
Radiol Clin North Am; 2009 Sep; 47(5):827-31, vi. PubMed ID: 19744597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
